Smoking Behavior and Healthcare Expenditure in the United States, 1992–2009: Panel Data Estimates
Open accessAbstract
BACKGROUND: Reductions in smoking in Arizona and California have been shown to be associated with reduced per capita healthcare expenditures in these states compared to control populations in the rest of the US. This paper extends that analysis to all states and estimates changes in healthcare expenditure attributable to changes in aggregate measures of smoking behavior in all states. METHODS AND FINDINGS: State per capita healthcare expenditure is modeled as a function of current smoking prevalence, mean cigarette consumption per smoker, other demographic and economic factors, and cross-sectional time trends using a fixed effects panel data regression on annual time series data for each the 50 states and the District of Columbia for the years 1992 through 2009. We found that 1% relative reductions in current smoking prevalence and mean packs smoked per current smoker are associated with 0.118% (standard error [SE] 0.0259%, p < 0.001) and 0.108% (SE 0.0253%, p < 0.001) reductions in per capita healthcare expenditure (elasticities). The results of this study are subject to the limitations of analysis of aggregate observational data, particularly that a study of this nature that uses aggregate data and a relatively small sample size cannot, by itself, establish a causal connection between smoking behavior and healthcare costs. Historical regional variations in smoking behavior (including those due to the effects of state tobacco control programs, smoking restrictions, and differences in taxation) are associated with substantial differences in per capita healthcare expenditures across the United States. Those regions (and the states in them) that have lower smoking have substantially lower medical costs. Likewise, those that have higher smoking have higher medical costs. Sensitivity analysis confirmed that these results are robust. CONCLUSIONS: Changes in healthcare expenditure appear quickly after changes in smoking behavior. A 10% relative drop in smoking in every state is predicted to be followed by an expected $63 billion reduction (in 2012 US dollars) in healthcare expenditure the next year. State and national policies that reduce smoking should be part of short term healthcare cost containment.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Effective implementation and enforcement of tobacco control policies and interventions can both increase healthy life expectancy and decrease health-care costs.
“Effective implementation and enforcement of tobacco control policies and interventions can both increase healthy life expectancy and decrease health-care costs.”
From Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019 (2021) · cites this paper as [6]
The Introduction (page not provided) says reductions in smoking have substantial health benefits that reduce per-capita healthcare expenditures, and links tobacco-control programs to lower smoking and expenditure. It does not establish that implementing and enforcing those policies increases healthy life expectancy; that outcome was not assessed in the passages found. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The Financial Impact of Smoking on Health-Related Costs: A Review of the Literature
Max, W. (2001) · American Journal of Health Promotion · doi:10.4278/0890-1171-15.5.321 · Cited by 115 · see citing works
Might Stopping Smoking Reduce Injury Death Risks? A Meta-analysis of Randomized, Controlled Trials
Leistikow, B. N., & Shipley, M. J. (1999) · Preventive Medicine · doi:10.1006/pmed.1998.0412 · Cited by 33 · see citing works
Flagged first, then by citations
Research works printed but not linked: 27
- [2]Carter BD, Abnet CC, Feskanich D, Freedman ND, Hartge P, et al (2015) Smoking and mortality—beyond established causes. N Engl J Med 372: 631– 640. 10.1056/NEJMsa1407211 25671255 · DOI · Paper page
- [3]Lightwood JM, Glantz SA (1997) Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke. Circulation 96: 1089– 1096. 9286934
- [4]Lightwood JM, Phibbs CS, Glantz SA (1999) Short-term health and economic benefits of smoking cessation: low birth weight. Pediatrics 104: 1312– 1320. 10585982
- [5]Pelkonen M, Notkola I, Tukiainen H, Tervahauta M, Tuomilehto J, et al (2001) Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the Seven Countries Study. Thorax 56: 703– 707. 11514691 PMC1746131
- [6]Sloan FA, Ostermann J, Picone G, Conover C, Taylor D Jr (2004) The price of smoking Cambridge (Massachusetts): MIT Press.
- [7]Vander Weg MW, Rosenthal GE, Vaughan Sarrazin M (2012) Smoking bans linked to lower hospitalizations for heart attacks and lung disease among Medicare beneficiaries. Health Aff (Millwood) 31: 2699– 2707. 23213154
- [8]Been JV, Nurmatov UB, Cox B, Nawrot TS, van Schayck CP, et al (2014) Effect of smoke-free legislation on perinatal and child health: a systematic review and meta-analysis. Lancet 383: 1549– 1560. 10.1016/S0140-6736(14)60082-9 24680633 · DOI
- [9]Millett C, Lee JT, Laverty AA, Glantz SA, Majeed A (2013) Hospital admissions for childhood asthma after smoke-free legislation in England. Pediatrics 131: e495– e501. 10.1542/peds.2012-2592 23339216 PMC4528337 · DOI
- [10]Barnoya J, Glantz S (2004) Association of the California tobacco control program with declines in lung cancer incidence. Cancer Causes Control 15: 689– 695. 15280627
- [11]Pierce JP, Messer K, White MM, Kealey S, Cowling DW (2010) Forty years of faster decline in cigarette smoking in California explains current lower lung cancer rates. Cancer Epidemiol Biomarkers Prev 19: 2801– 2810. 10.1158/1055-9965.EPI-10-0563 20852009 · DOI
- [12]Lightwood JM, Dinno A, Glantz SA (2008) Effect of the California tobacco control program on personal health care expenditures. PLoS Med 5: e178 10.1371/journal.pmed.0050178 18752344 PMC2522256 · DOI
- [13]Lightwood J, Glantz S (2013) The effect of the California tobacco control program on smoking prevalence, cigarette consumption, and healthcare costs: 1985–2008. PLoS ONE 8: e47145 10.1371/journal.pone.0047145 23418411 PMC3572143 · DOI
- [14]Lightwood J, Glantz S (2011) Effect of the Arizona tobacco control program on cigarette consumption and healthcare expenditures. Soc Sci Med 72: 166– 172. 10.1016/j.socscimed.2010.11.015 21168248 PMC3603372 · DOI
- [15]Ebarhardt M (2009) Nonstationary panel econometrics and common factor models: an introductory reader Oxford: Oxford University Department of Economics. 60 pp.
- [16]Kapetanios G, Pesaran M, Yamagata T (2009) Panels with nonstationary multifactor error structures Cambridge: University of Cambridge Department of Economics.
- [20]Orzechowski W, Walker RC (2009) The tax burden on tobacco, vol. 44 Arlington (Virginia): Orzechowski & Walker.
- [28]Fix B, Hyland A, O’Connor R, Cummings K, Fong G, et al (2013) A novel approach to estimating the prevalence of untaxed cigarettes in the USA: findings from the 2009 and 2010 international tobacco control surveys. BMJ 23: i61– i66. PMC3984758 23970794
- [29]Davis K, Grimshaw V, Merriman D, Farrelly M, Chernick H, et al (2014) Cigarette trafficking in five northeastern US cities. Tob Control 23: e62– e68. 10.1136/tobaccocontrol-2013-051244 24335338 · DOI
- [31]Max W, Rice D, Sung H, Zhang X, Miller L (2004) The economic burden of smoking in California. Tob Control 13: 264– 267. 15333882 PMC1747911
- [32]Burton A (2011) Does the smoke ever clear? Environ Health Perspect 119: A71– A74. PMC3040625 21285011
- [33]Max W, Sung H, Lightwood J (2013) The impact of changes in tobacco control funding on healthcare expenditures in California, 2012–2016. Tob Control 22: e10– 5. 22253003
- [34]Warner KE, Fulton GA, Nicolas P, Grimes DR (1996) Employment implications of declining tobacco product sales for the regional economies of the United States. JAMA 275: 1241– 1246. 8601955
- [36]Leistikow BN (2009) Smoking and ischemic heart disease disparities between studies, genders, times, and socioeconomic strata. J Cardiovasc Transl Res 2: 267– 273. 10.1007/s12265-009-9113-x 19654885 PMC2719731 · DOI
- [37]Leistikow BN (2009) Are most cancer deaths in more developed nations now from smoking? Recent smoke load/cancer death association trends. Future Oncol 5: 413– 416. 10.2217/fon.09.27 19450169 · DOI
- [38]Leistikow BN, Kabir Z, Connolly GN, Clancy L, Alpert HR (2008) Male tobacco smoke load and non-lung cancer mortality associations in Massachusetts. BMC Cancer 8: 341 10.1186/1471-2407-8-341 19025639 PMC2606690 · DOI
- [39]Leistikow BN, Martin DC, Samuels SJ (2000) Injury death excesses in smokers: a 1990–95 United States national cohort study. Inj Prev 6: 277– 280. 11144627 PMC1730660
- [45]Warner KE, Hodgson TA, Carroll CE (1999) Medical costs of smoking in the United States: estimates, their validity, and their implications. Tob Control 8: 290– 300. 10599574 PMC1763946
Cited by
Sorted by citations
Reitsma, M. B., Kendrick, P. J., Ababneh, E., Abbafati, C., Abbasi-Kangevari, M., Abdoli, A., Abedi, A., Abhilash, E. S., Abila, D. B., Aboyans, V., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01169-7 · Cited by 1,759 · see citing works
- Authors
- Lightwood, J., & Glantz, S. A.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Glantz, Stanton A.
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-05-10
- Volume
- 13
- Issue
- 5
- Pages
- e1002020
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC4862673
- OpenAlex
- W2374864284
- Cited by
- 36
- References
- 2
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 5 · 2022: 3 · 2021: 5 · 2020: 6 · 2019: 4 · 2018: 5 · 2017: 3 · 2016: 2
- FWCI
- 3.76
- Type
- journal article
- Language
- en
- Update notices
- correction (2016-06-15)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Cancer Institute (CA-61021)
- Topics
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
- Health Sciences › Health Professions › General Health Professions › Global Health Care Issues
- Keywords
- smoking prevalence, health care expenditure, cigarette consumption, tobacco control, smoking restrictions, tobacco taxation, health care cost containment, state-level variation
- MeSH terms
- Cross-Sectional Studies, Health Expenditures, Humans, Public Health, Smoking, United States, Program Evaluation, Prevalence, Health Care Costs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review